Lamivudine 300 mg/1 (Lamivudine TABLET, FILM COATED) 300 mg/1

Lamivudine 300 mg is an antiviral medication used to manage HIV and hepatitis B. It works by slowing the growth of viruses in the body. This film-coated tablet is manufactured by Camber Pharmaceuticals, Inc.

Strength

300 mg/1

Pack Size

100 TABLET, FILM COATED in 1 CARTON (31722-754-32)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lamivudine 300 mg is primarily used as part of combination therapy to treat HIV-1 infection in adults and children. It is also used to manage chronic hepatitis B in adults. This medication helps control the virus, reducing its ability to replicate and spread. Lamivudine is often prescribed alongside other antiviral drugs to enhance effectiveness.

Side Effects

Common effects of Lamivudine 300 mg may include headache, nausea, fatigue, and cough. Some users might experience dizziness, insomnia, or abdominal pain. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Lamivudine 300 mg should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not share this medication with others, even if they have similar symptoms. Always follow the prescribed dosage and instructions provided by your healthcare provider.

Avoid Interactions

Lamivudine 300 mg may interact with other medications, including certain antiviral drugs, chemotherapy agents, and immunosuppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with your healthcare provider.

Frequently Asked Questions

Lamivudine 300 mg is used to treat HIV-1 infection and chronic hepatitis B as part of combination therapy.

Lamivudine 300 mg is taken orally, typically once or twice daily, as prescribed by your healthcare provider.

Common side effects may include headache, nausea, fatigue, and cough. Always consult your healthcare provider for personalized advice.

Discuss alcohol consumption with your healthcare provider, as it may interact with Lamivudine 300 mg.

Store Lamivudine 300 mg at room temperature, away from moisture and heat, and keep it out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.